Busulphan

DRUG2 trials

Sponsors

King's College Hospital NHS Trust, University of Birmingham

Conditions

Acute Myeloid LeukaemiaHigh-risk Myelodysplastic SyndromeLeukemia, Myeloid, AcuteMyelodysplastic Syndromes

Phase 2

Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin

TerminatedNCT00915811

King's College Hospital NHS TrustLeukemia, Myeloid, Acute, Myelodysplastic Syndromes

Start: 2007-06-30End: 2011-06-30Target: 20Updated: 2011-08-17

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Active, not recruitingNCT04217278

University of BirminghamAcute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome

Start: 2020-01-27End: 2026-05-01Updated: 2026-05-05